Contrast Staining in Noninfarcted Tissue after Endovascular Treatment of Acute Ischemic Stroke
American Journal of Neuroradiology · 2024
DOI: 10.3174/ajnr.a8222 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Neuroradiology, 2024. Verfasst von Mohamad Abdalkader und 12 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Radiology (M.A., T.N.N., A.S., M.M.Q., P.K., A.Z.M., B.N.S.), Boston Medical Center, Boston University Chobanian & Avedisian S…. Hauptthemen laut MEDLINE: Ischemic Stroke, Endovascular Procedures, Contrast Media, Brain. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND AND PURPOSE: Contrast staining is a common finding after endovascular treatment of acute ischemic stroke. It typically occurs in infarcted tissue and is considered an indicator of irreversible brain damage. Contrast staining in noninfarcted tissue has not been systematically investigated. We sought to assess the incidence, risk factors, and clinical significance of contrast staining in noninfarcted tissue after endovascular treatment. MATERIALS AND METHODS: We conducted a retrospective review of consecutive patients who underwent endovascular treatment for anterior circulation large-vessel occlusion acute ischemic stroke. Contrast staining, defined as new hyperdensity on CT after endovascular treatment, was categorized as either contrast staining in infarcted tissue if the stained region demonstrated restricted diffusion on follow-up MR imaging or contrast staining in noninfarcted tissue if the stained region demonstrated no restricted diffusion. Baseline differences between patients with and without contrast staining in noninfarcted tissue were compared. Logistic regression was used to identify independent associations for contrast staining in noninfarcted tissue after endovascular treatment. RESULTS: Among 194 patients who underwent endovascular treatment for large-vessel occlusion acute ischemic stroke and met the inclusion criteria, contrast staining in infarcted tissue was noted in 52/194 (26.8%) patients; contrast staining in noninfarcted tissue, in 26 (13.4%) patients. Both contrast staining in infarcted tissue and contrast staining in noninfarcted tissue were noted in 5.6% (11/194). Patients with contrast staining in noninfarcted tissue were found to have a higher likelihood of having an ASPECTS of 8-10, to be associated with contrast staining in infarcted tissue, and to achieve successful reperfusion compared with those without contrast staining in noninfarcted tissue. In contrast staining in noninfarcted tissue regions, the average attenuation was 40 HU, significantly lower than the contrast staining in infarcted tissue regions (53 HU). None of the patients with contrast staining in noninfarcted tissue had clinical worsening during their hospital stay. The median discharge mRS was significantly lower in patients with contrast staining in noninfarcted tissue than in those without (3 versus 4; P = .018). No independent predictors of contrast staining in noninfarcted tissue were found. CONCLUSIONS: Contrast staining can be seen outside the infarcted tissue after endovascular treatment of acute ischemic stroke, likely attributable to the reversible disruption of the BBB in ischemic but not infarcted tissue. While generally benign, understanding its characteristics is important because it may mimic pathologic conditions such as infarcted tissue and cerebral edema.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Radiology (M.A., T.N.N., A.S., M.M.Q., P.K., A.Z.M., B.N.S.), Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts Mohamad.abdalkader@bmc.org.
- From the Department of Radiology (M.A., T.N.N., A.S., M.M.Q., P.K., A.Z.M., B.N.S.), Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
- Department of Neurology (T.N.N., C.J.O.), Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
- Department of Neurology (C.J.O.), Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts.
- Department of Medicine (M.I.M.), Cambridge Health Alliance, Cambridge, Massachusetts.
- Institute of Diagnostic and Interventional Neuroradiology, Institute of Diagnostic, Interventional and Pediatric Radiology and Department of Neurology (J.K., A.M.), Inselspital, Bern University Hospital, and University…
ORCID-Profile: Mohamad Abdalkader, Thanh N Nguyen, Anurag Sahoo, Muhammad M Qureshi, Piers Klein, Matthew I Miller, Asim Z Mian, Johannes Kaesmacher, Adnan Mujanovic, Hui Sheng Chen, Bindu N Setty
Zitieren
APA
Abdalkader, M., Nguyen, T. N., Sahoo, A., Qureshi, M. M., Ong, C. J., Klein, P., Miller, M. I., Mian, A. Z., Kaesmacher, J., Mujanovic, A., Hu, W., Chen, H. S., & Setty, B. N. (2024). Contrast Staining in Noninfarcted Tissue after Endovascular Treatment of Acute Ischemic Stroke. American Journal of Neuroradiology. https://doi.org/10.3174/ajnr.a8222
Vancouver
Abdalkader M, Nguyen TN, Sahoo A, Qureshi MM, Ong CJ, Klein P, et al. Contrast Staining in Noninfarcted Tissue after Endovascular Treatment of Acute Ischemic Stroke. American Journal of Neuroradiology. 2024. doi:10.3174/ajnr.a8222
BibTeX
@article{Abdalkader2024,
author = {Abdalkader, Mohamad and Nguyen, Thanh N and Sahoo, Anurag and Qureshi, Muhammad M and Ong, Charlene J and Klein, Piers and Miller, Matthew I and Mian, Asim Z and Kaesmacher, Johannes and Mujanovic, Adnan and Hu, Wei and Chen, Hui Sheng and Setty, Bindu N},
title = {Contrast Staining in Noninfarcted Tissue after Endovascular Treatment of Acute Ischemic Stroke},
journal = {American Journal of Neuroradiology},
year = {2024},
doi = {10.3174/ajnr.a8222}
}
EUVIMED